Anatomical Distinctions between the Two Basal Ganglia Afferent Territories in the Primate Motor Thalamus1Ilinsky I.A. · Tourtellotte W.G. · Kultas-Ilinsky K.
Department of Anatomy, University of Iowa College of Medicine, Iowa City, Iowa, USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
In primates, the efferents of the two basal ganglia output structures, medial globus pallidus and substantia nigra pars reticularis, are completely segregated and target different thalamic regions. Despite similarities demonstrated earlier in non-primate species in the functional properties and ultrastructural features of the termi-nals of the two pathways, the present findings suggest significant differences between thalamic circuits associated with the two systems in primates. The data presented in this report further support the concept on functional and anatomical diversity of the subdivisions of the primate motor thalamus proposed in 1990 by Hinsky.
© 1993 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.